-
121.发明公开Method and apparatus for controlling information processing in a network of interactive elements 审中-公开用于交互式元件的网络中的控制数据处理的方法和装置
公开(公告)号：EP0984365A3
公开(公告)日：2005-03-30
申请号：EP99306339.5
申请日：1999-08-11
Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
Inventor： Markram, Henry, QED I.P. Servces Limited
CPC classification number: G06N3/049
Abstract: A process and apparatus that enable continual self-adaptation of dynamic transmission devices (saSTDs), allow "smart" filtering of information for transmission from one element to another within a network of interacting elements, such as a "neural network". An adaptation algorithm (MapSA) incorporated in STDs allows multiple parameters of STDs (which determine its filtering properties) to continuously adapt simultaneously and interdependently. In this manner, complex correlations can be established between the parameters in all STDs within a network of interacting elements. The process according to the invention therefore establishes unique patterns of connection parameters within the network which in turn dictates a novel sequence of information processing steps by the network.
-
公开(公告)号：EP0912611B9
公开(公告)日：2004-12-01
申请号：EP97924227.8
申请日：1997-06-10
Inventor： REISNER, Yair , DAGAN, Shlomo
IPC: C07K16/08 , A61K39/29 , A61K39/42 , C12N5/28 , G01N33/569 , G01N33/577
CPC classification number: A01K67/0271 , A61K38/00 , A61K39/00 , C07K16/082
Abstract: Disclosed is a process for obtaining hybridoma cell lines which produce human antibodies capable of binding to the hepatitis B virus surface antigen (HBVsAg), as well as the hybridoma cell lines, and antibodies produced by the cell lines. Also disclosed are various uses of said antibodies in the prevention and treatment of HBV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HBVsAg antibodies are engrafted into normal strains of mice which were lethally irradiated and radioprotected with SCID bone marrow. After immunization of such chimeric mice with HBVsAg, human cells are obtained from the mice spleens and fused in vitro with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HBVsAg.
-
公开(公告)号：EP0606869B1
公开(公告)日：2003-04-09
申请号：EP94100243.8
申请日：1994-01-10
Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
Inventor： Wallach, David , Kemper, Oliver
IPC: C12N15/85 , A61K31/7088 , C12Q1/68
CPC classification number: C12N15/1138 , C12N15/85 , C12N2310/13 , C12N2830/00 , C12N2830/85
-
公开(公告)号：EP1254092A1
公开(公告)日：2002-11-06
申请号：EP00907546.6
申请日：2000-02-11
Applicant: Degussa AG , YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
Inventor： KOTTENHAHN, Matthias , KNAUP, Günter , DRAUZ, Karlheinz , LAHAV, Meir,c/o Weizmann Institute of Science , ZBAIDA, David
IPC: C07B57/00 , C07C209/88 , C07C231/20 , C07C227/34
CPC classification number: C07D233/64 , C07B57/00 , C07B2200/07 , C07C201/16 , C07C227/34 , C07C231/20 , C07C319/28 , C07C229/08 , C07C229/22 , C07C229/24 , C07C237/06 , C07C323/58 , C07C205/57
Abstract: The present invention relates to a process for the resolution of DL-racemic mixtures of compounds which crystalize in the form of a conglumerate. Both, the D and L-enantiomers are obtained according to the invention in a industrially feasable process by adding chiral enantioselective polymers to the supersaturated solution of the racemat to inhibit crystalization of one enantiomer. Next a DL-racemic mixture of said compound is suspended in about twice the amount of the crystallized enantiomer. Consequently, the opposite enantiomer could be recovered by said suspension by physical separation.
-
125.发明公开BULK SYNTHESIS OF LONG NANOTUBES OF TRANSITION METAL CHALCOGENIDES 有权LONG碳纳米管从过渡金属硫属化合物PRODUCTION MASS
公开(公告)号：EP1177153A1
公开(公告)日：2002-02-06
申请号：EP00921021.2
申请日：2000-05-02
Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
Inventor： TENNE, Reshef , ROTHSCHILD, Aude , HOMYONFER, Moshe
CPC classification number: G01Q70/12 , C01B17/20 , C01B19/02 , C01G41/00 , C01G41/02 , C01P2002/72 , C01P2002/74 , C01P2002/82 , C01P2004/03 , C01P2004/04 , C01P2004/13 , C01P2004/62 , C01P2004/64 , C01P2006/10 , C01P2006/60 , C30B25/005 , C30B29/46 , C30B29/605 , Y10S977/844
Abstract: Nanotubes of transition metal chalcogenides as long as 0.2-20 microns or more, perfect in shape and of high crystallinity, are synthesized from a transition metal material, e.g., the transition metal itself or a substance comprising a transition metal such as an oxide, water vapor and a H 2 X gas or H 2 gas and X vapor, wherein X is S, Se or Te, by a two-step or three-step method. The transition metal chalcogenide is preferably WS 2 or WSe 2 . Tips for scanning probe microscopy can be prepared from said long transition metal chalcogenide nanotubes.
-
Patent Agency Ranking126.发明授权Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them 失效叶绿素和细菌叶绿素衍生物，它们的制备和含有它们的药物组合物
公开(公告)号：EP0584552B1
公开(公告)日：2000-10-11
申请号：EP93111942.4
申请日：1993-07-26
Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
Inventor： Scherz, Avigdor , Salomon, Yoram , Fiedor, Leszek
CPC classification number: A61K49/0036 , A61K41/0071 , A61K47/64 , A61K47/6803 , A61K47/6851 , A61K49/00 , A61K49/0052 , A61K49/0056 , C07K14/685 , C07K14/795 , C12N9/18 , C12P17/182
-
127.发明公开Method and apparatus for memory efficient variants of public key encryption and identification schemes for smart card applications 失效与公钥Verschlüssungs-和标识方案可存储的变种，在智能卡的使用方法和设备。
公开(公告)号：EP0682327A3
公开(公告)日：1999-11-03
申请号：EP95106967.3
申请日：1995-05-09
Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
Inventor： Shamir, Adi
CPC classification number: G07F7/1008 , G06Q20/341 , G06Q20/40975 , H04L9/0869 , H04L9/302 , H04L9/3218 , H04L9/3234
Abstract: Memory efficient variants of public key encryption and identification schemes for smart card applications with severely limited RAM without using dedicated coprocessors. The variants replace the memory-intensive modular multiplication operation z = x*y (mod n) by a new randomized multiplication operation z' = x*y + r*n , where r is a randomly chosen integer in a suitable range [0,b], and a double convolution process to compute z'is used. Method and apparatus are described.
-
公开(公告)号：EP0912611A1
公开(公告)日：1999-05-06
申请号：EP97924227.0
申请日：1997-06-10
Inventor： REISNER, Yair , DAGAN, Shlomo
CPC classification number: A01K67/0271 , A61K38/00 , A61K39/00 , C07K16/082
Abstract: Disclosed is a process for obtaining hybridoma cell lines which produce human antibodies capable of binding to the hepatitis B virus surface antigen (HBVsAg), as well as the hybridoma cell lines, and antibodies produced by the cell lines. Also disclosed are various uses of said antibodies in the prevention and treatment of HBV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HBVsAg antibodies are engrafted into normal strains of mice which were lethally irradiated and radioprotected with SCID bone marrow. After immunization of such chimeric mice with HBVsAg, human cells are obtained from the mice spleens and fused in vitro with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HBVsAg.
-
129.发明授权METHODS AND COMPOSITIONS FOR CANCER THERAPY AND FOR PROGNOSTICATING RESPONSES TO CANCER THERAPY 失效方法和组合物用于癌症治疗和反应的可预测性对这种治疗
公开(公告)号：EP0554441B1
公开(公告)日：1999-01-27
申请号：EP92918871.2
申请日：1992-08-21
Inventor： BACUS, Sarah, S. , YARDEN, Yosef , SELA, Michael
IPC: G01N33/50 , C07K16/32 , A61K39/395
CPC classification number: G01N33/5011 , A61K38/00 , A61K47/6855 , C07K16/3015 , C07K16/32 , C07K2317/73
Abstract: A method for determining the efficacy of a therapeutic agent, in vitro, for a cancer expressing or overexpressing an oncogene product is described. The method is particularly useful for determining the efficacy of therapeutic agents that have a binding affinity for cancer that express HER-2/neu. N24, N28 and N29 monoclonal antibodies are described which have been identified by this method. One or more of these antibodies can be used as a therapeutic agent in the treatment of breast, stomach, ovarian or salivary cancers.
-
公开(公告)号：EP0852587A2
公开(公告)日：1998-07-15
申请号：EP96931220.0
申请日：1996-09-26
Applicant: YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD.
CPC classification number: C07K14/7155 , A61K38/00
Abstract: Novel peptides derived from the gp80 subunit of the IL-6 receptor system which inhibit the activity of IL-6 are provided.
-
-
-
-
-
-
-
-
-
Search Results
276
records
(took 0.045 seconds)
